Remgro Ltd Ord (RMGOF) Q4 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day ladies and gentlemen, and welcome to the Remgrove Limited annual results. All participants will be in listen-only mode. If you have joined via the webcast link, there will be a presentation visible throughout the event. If you have joined via the HD web phone, there will only be audio and a keypad on the screen. There will be an opportunity to ask questions later during the conference. If you should need assistance during the call, Please signal an operator by pressing star, then zero. Please note that this call is being recorded. I would now like to turn the conference over to Yanni Durand, CEO. Please go ahead. Good morning everybody and welcome to the annual results presentation of Remgrove Limited for the year ended 30 June 2023. Just to run you through the contents of the day, I will start by giving a performance overview. We will rate ourselves against our strategic priorities and then I'll also briefly discuss the operating context of the environment that we've been operating during the past 12 months. Then I will hand over to Neville to give a more detailed overview of our results for the year. And then we deviated a little bit from our usual format in previous years. We will then begin an update on some of our key investments. And I welcome Ronnie van der Merwe and Jurgens Meijberg, the CEO and the CFO respectively of Mediclinic, who will speak to the results of Mediclinic as well as their strategy. Then Peter Ace, the chairperson of CIVH, will also do exactly the same for our CIVH company. And finally, we've got Paul Kruschenk also on the line, the CEO of RCL, that will speak to RCL's strategy and most recent performance as well. I will then close off with our key areas of focus, looking ahead, and then also open the floor for questions right at th...